Decline in coronary mortality in Sweden between 1986 and 2002: Comparing contributions from primary and secondary prevention

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Björck, Lena ^a   Capewell, Simon ^b   O'Flaherty, Martin ^b   Lappas, Georgios ^a   Bennett, Kathleen ^c   Rosengren, Annika ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEALTH PROMOTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; POPULATION SIZE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SEX DIFFERENCE; SMOKING; SWEDEN; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; CORONARY DISEASE; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PROCEDURES; SMOKING CESSATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHOLESTEROL; CORONARY DISEASE; HUMANS; MIDDLE AGED; RISK FACTORS; SECONDARY PREVENTION; SMOKING; SMOKING CESSATION; SWEDEN;

EID: 84929094212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124769     Document Type: Article

References (28)

1. Bjorck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J. 2009; 30: 1046-56. doi: 10.1093/eurheartj/ehn554 PMID: 19141562
2. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur Heart J. 2013; 34: 3028-34. doi: 10.1093/eurheartj/eht356 PMID: 24014390
3. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999; 81: 380-86. PMID: 10092564
4. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U. S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356: 2388-98. PMID: 17554120
5. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004; 109: 1101-07. PMID: 14993137
6. Rose G. Sick individuals and sick populations. Int J Epidemiol. 2001; 30: 427-32; discussion 433-24. PMID: 11416056
7. Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Mannisto S, Sundvall J, et al.Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010; 39: 504-18. doi: 10.1093/ije/dyp330 PMID: 19959603
8. Kabir Z, Bennett K, Shelley E, Unal B, Critchley JA, Capewell S. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000. BMC Public Health. 2007; 7: 117. PMID: 17584932
9. Young F, Capewell S, Ford ES, Critchley JA. Coronary mortality declines in the U.S. between 1980 and 2000 quantifying the contributions from primary and secondary prevention. Am J Prev Med. 2010; 39: 228-34. doi: 10.1016/j.amepre.2010.05.009 PMID: 20709254
10. Bjorck L, Rosengren A, Bennett K, Lappas, G, Capewell, S. Impact, a validated, comprehensive coronary heart disease model: supplementary appendix for the Swedish. Eur Heart J website. Available: model.http://eurheartj.oxfordjournals.org/content/suppl/2008/11/24/ehn554.DC1/ehn554supp.pdf Accessed 1 Feb 2015.
11. Mant J, Hicks N. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ. 1995; 311: 793-96. PMID: 7580444
12. Unal B, Sozmen K, Arik H, Gerceklioglu G, Altun DU, Şimşek H, et al. Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008. BMC Public Health. 2013; 13: 1135. doi: 10.1186/1471-2458-13-1135 PMID: 24308515
13. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001; 358:2026-33. PMID: 11755609
14. Wilhelmsen L, Johansson S, Rosengren A, Wallin I, Dotevall A, Lappas G. Risk factors for cardiovascular disease during the period 1985-1995 in Goteborg, Sweden. The GOT-MONICA Project. J Intern Med. 1997; 242: 199-211. PMID: 9350164
15. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001; 22: 554-72. PMID: 11259143
16. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R.Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-13. PMID: 12493255
17. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937-52. PMID: 15364185
18. Nichol MB, Venturini F, Sung JC. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother. 1999; 33: 531-540. PMID: 10369613
19. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ. 1994; 3: 95-104. PMID: 8044216
20. The Swedish Council of Technology Assessment in Health Care (SBU Statens beredning för medicinsk utvärdering) (2004). Moderately Elevated Blood Pressure, no 2. Stockholm).
21. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994; 308: 367-72. PMID: 8043072
22. Butler J, Arbogast PG, BeLue R, Daugherty J, Jain MK, Ray WA, et al. Outpatient adherence to betablocker therapy after acute myocardial infarction. J Am Coll Cardiol. 2002; 40: 1589-95. PMID: 12427410
23. Cooney MT, Kotseva K, Dudina A, De Backer G, Wood D, Graham I. Determinants of risk factor control in subjects with coronary heart disease: a report from the EUROASPIRE III investigators. Eur J Prev Cardiol. 2013; 20: 686-91. doi: 10.1177/2047487312445562 PMID: 22514212
24. Teo K, Lear S, Islam S, Mony P, Dehghan M, Li W, et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study. JAMA. 2013; 309: 1613-21. doi: 10.1001/jama.2013.3519 PMID: 23592106
25. Dudas K, Lappas G, Stewart S, Rosengren A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation. 2011; 123: 46-52. doi: 10.1161/CIRCULATIONAHA.110.964999 PMID: 21173352
26. Berg J, Bjorck L, Lappas G, O'Flaherty M, Capewell S, Rosengren A. Continuing decrease in coronary heart disease mortality in Sweden. BMC Cardiovasc Disord. 2014; 14: 9. doi: 10.1186/1471-2261-14-9 PMID: 24447603
27. Lindblad U, Ek J, Eckner J, Larsson CA, Shan G, Råstam L. Prevalence, awareness, treatment, and control of hypertension: rule of thirds in the Skaraborg project. Scand J Prim Health Care. 2012; 30: 88-94. doi: 10.3109/02813432.2012.684207 PMID: 22643153
28. Socialstyrelsen website. Available: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/17974/2010-3-28.pdf Accessed 1 Feb 2015.